Topics

Brexit's Disruptive Impact On U.K. And European Prescription Drug Market

10:23 EDT 15 Aug 2019 | Forbes

In brief, a no-deal Brexit would imply an unprecedented disruption of the European pharmaceuticals market in terms of research, regulation, manufacture, and trade in biopharmaceuticals. It would even impact drug prices as reference pricing schemes throughout the E.U. would need to be altered.

Original Article: Brexit's Disruptive Impact On U.K. And European Prescription Drug Market

NEXT ARTICLE

More From BioPortfolio on "Brexit's Disruptive Impact On U.K. And European Prescription Drug Market"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...